BIOTRONIK Conduction System Pacing With the Solia Lead - Solia CSP S

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 192 participants.

Also called NCT06540079

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 192 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT06540079
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT06540079. Allocation not applicable; no masking; primary purpose treatment. Start 2024-12-18 (actual); primary completion 2025-09-18 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
BIOTRONIK Conduction System Pacing With the Solia Lead - Solia CSP S
Acronym
BIO-CONDUCT
Condition
Sinus Node Dysfunction
Condition
Bradycardia
Condition
Atrioventricular Block
Intervention (Device)
Solia CSP S lead
Lead sponsor
Biotronik, Inc. (class: industry)

Record details

Record id
cardio:ct-nct06540079
Content hash
a27565e66d3b82d12bc1eea0c7553850eded1b38983f88209f1d811fb94e3d22